Jim Easton Consortium - Project 4: Biomarkers in Familial Alzheimer's Disease (FAD)

Research suggests that brain changes may occur years before actual Alzheimer's symptoms are detected. The major goal of Biomarkers in Familial Alzheimer's Disease (FAD) is to study these changes in people who carry an Alzheimer's disease (AD) mutation to determine how the disease process develops before there are any symptoms. Ultimately, knowledge gained from Biomarkers in FAD study may lead to tests that detect people who still are normal but are at very high risk of developing dementia caused by Alzheimer's disease.

Ringman, John M., M.D., M.S.
John Ringman, MD, MS - Professor and Neurologist specializes in Alzheimer's disease, dementia and memory disorders, Easton Center for Alzheimer's Disease Research at UCLA
Clinical Professor of Neurology, David Geffen School of Medicine at UCLA
Associate Clinical Director, Mary S. Easton Center for Alzheimer's Disease Research at UCLA
Specialty: Neurology, Alzheimer's Disease, Dementia, and Memory Disorders.
Tel: (310) 794-3665
Fax: (310) 794-3148
Appts: (310) 794-6039 Memory Eval
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.